Nrf2

Japan Society for the Promotion of ScienceJP¥88.3mNational Institute on AgingUS$758.7kNational Heart, Lung, and Blood InstituteUS$2.3m

• Nrf2エピゲノム修飾制御による老視および加齢白内障進行抑制に関する研究

  Japan Society for the Promotion of ScienceKanazawa Medical UniversityJP¥4.6m2026–2029

• Skeletal Muscle Nrf2: Exercise-Induced Cardiovascular Protection

  National Heart, Lung, and Blood InstituteUniversity of Nebraska Medical CenterUS$518.5k2022–2026

• Repurposing of FDA-approved Nrf2 Activators as a Novel Inhaled Therapy for Pulmonary Fibrosis

  National Heart, Lung, and Blood InstituteFibronoxUS$286.7k2024–2027

• Development of a novel therapeutic strategy of dysphagia focusing on the cell-protection and anti-inflammatory effects of the transcription factor Nrf2.

  Japan Society for the Promotion of ScienceTohoku UniversityJP¥16.3m2024–2025

• The role of mitochondrial redox stress in the impaired Nrf2 response to contraction in aged muscle

  National Institute on AgingUniversity of WashingtonUS$74.3k2021–2024

• Treatment strategy to enhance Nrf2 signaling in older adults: combining acute exercise with the phytochemical sulforaphane

  National Institute on AgingNorthern Arizona UniversityUS$448.8k2022–2025

• Elucidation of a novel preventive mechanism for age-related hearing loss targeting the transcription factor Nrf2 and ferroptotic cell death.

  Japan Society for the Promotion of ScienceTohoku UniversityJP¥4.7m2021–2025

• Localization and pathogenesis of inner ear oxidative stress injury using NRF2 activation monitoring mice.

  Japan Society for the Promotion of ScienceTohoku UniversityJP¥4.4m2021–2024

• Nrf2, a transcription facor for anti-oxidative stress response, ameliorates sarcopenia in obese subjects.

  Japan Society for the Promotion of ScienceUniversity of TsukubaJP¥17.9m2020–2023

• GLP1 receptor agonist Liraglutide and NRF2 activator RTA-408 therapy to relieve neurodegenerative symptoms in rat model of Wolfram syndrome

  Eesti Teadusagentuur2020–2024